Peptidream Inc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Peptidream Inc with three other
companies in this sector in Japan:
Trans Genic Inc
sales of 2.29 billion Japanese Yen [US$20.50 million]
of which 48%
was CRO Business),
Medical Data Vision Co Ltd
(2.63 billion Japanese Yen [US$23.56 million]
of which 55%
was Data network service), and
Symbio Pharmaceuticals Ltd
(2.37 billion Japanese Yen [US$21.19 million]
of which 100%
was Auxiliary Business).
During the year ended June of 2016, sales at
Peptidream Inc were ¥4.33 billion (US$38.73 million).
increase of 74.9%
versus 2015, when the company's sales were ¥2.47 billion.
This was the fourth straight year of sales growth at Peptidream Inc.